Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Loss, Surgical | 1 | 2020 | 656 | 0.530 |
Why?
|
| Fecal Impaction | 1 | 2013 | 32 | 0.440 |
Why?
|
| Jejunal Diseases | 1 | 2013 | 46 | 0.430 |
Why?
|
| Diverticulum | 1 | 2013 | 137 | 0.400 |
Why?
|
| Intestinal Perforation | 1 | 2013 | 250 | 0.380 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2020 | 2282 | 0.380 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2002 | 1246 | 0.270 |
Why?
|
| Neutrophils | 5 | 2002 | 3767 | 0.270 |
Why?
|
| Kupffer Cells | 2 | 2001 | 143 | 0.220 |
Why?
|
| Perioperative Period | 1 | 2020 | 264 | 0.160 |
Why?
|
| Pain, Postoperative | 3 | 2020 | 1720 | 0.150 |
Why?
|
| Interleukin-1 | 1 | 2002 | 1249 | 0.150 |
Why?
|
| Lipopolysaccharides | 4 | 2001 | 2209 | 0.150 |
Why?
|
| Apoptosis | 4 | 2002 | 9497 | 0.140 |
Why?
|
| Immune System | 1 | 2001 | 798 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2002 | 2913 | 0.120 |
Why?
|
| Nitric Oxide | 1 | 2000 | 2141 | 0.100 |
Why?
|
| Orthopedic Procedures | 1 | 2020 | 1263 | 0.090 |
Why?
|
| Perioperative Care | 1 | 2018 | 1037 | 0.090 |
Why?
|
| Analgesia | 1 | 2014 | 459 | 0.080 |
Why?
|
| Wounds and Injuries | 1 | 2002 | 2477 | 0.080 |
Why?
|
| Liver | 2 | 2001 | 7510 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2002 | 687 | 0.080 |
Why?
|
| Analgesics, Opioid | 3 | 2020 | 3763 | 0.070 |
Why?
|
| Manometry | 1 | 2009 | 453 | 0.070 |
Why?
|
| Medicare | 1 | 2023 | 6785 | 0.060 |
Why?
|
| Proton Pump Inhibitors | 1 | 2009 | 551 | 0.060 |
Why?
|
| Language | 2 | 2023 | 1533 | 0.060 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2009 | 867 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 6853 | 0.050 |
Why?
|
| Gastroesophageal Reflux | 1 | 2009 | 816 | 0.050 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2006 | 508 | 0.050 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2009 | 936 | 0.050 |
Why?
|
| Haiti | 1 | 2023 | 549 | 0.050 |
Why?
|
| Acute-Phase Reaction | 1 | 2001 | 91 | 0.050 |
Why?
|
| Ischemic Preconditioning | 1 | 2001 | 89 | 0.050 |
Why?
|
| Monokines | 1 | 2000 | 71 | 0.040 |
Why?
|
| Nitrites | 1 | 2000 | 159 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2009 | 1940 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2000 | 1849 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 2176 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2002 | 476 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2000 | 514 | 0.040 |
Why?
|
| Endotoxemia | 1 | 2000 | 196 | 0.040 |
Why?
|
| Early Detection of Cancer | 2 | 2023 | 3202 | 0.040 |
Why?
|
| Flavonoids | 1 | 2001 | 445 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2000 | 548 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2000 | 908 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2000 | 653 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 666 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2000 | 1342 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 2001 | 1199 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 21029 | 0.030 |
Why?
|
| Humans | 13 | 2023 | 760613 | 0.030 |
Why?
|
| Imidazoles | 1 | 2001 | 1180 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2001 | 1557 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2006 | 2821 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2001 | 1483 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2001 | 3725 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2001 | 8311 | 0.030 |
Why?
|
| Cell Communication | 1 | 2000 | 1653 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 74333 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2000 | 2104 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2000 | 4356 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2000 | 2486 | 0.020 |
Why?
|
| Male | 7 | 2023 | 359718 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20509 | 0.020 |
Why?
|
| Pyridines | 1 | 2001 | 2879 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2001 | 2325 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2014 | 805 | 0.020 |
Why?
|
| Mental Health | 1 | 2022 | 3213 | 0.020 |
Why?
|
| Critical Illness | 1 | 2001 | 2709 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 5349 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2000 | 18955 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 3386 | 0.020 |
Why?
|
| Rats | 2 | 2000 | 23709 | 0.020 |
Why?
|
| Analgesics | 1 | 2014 | 1065 | 0.020 |
Why?
|
| Cytokines | 1 | 2001 | 7344 | 0.020 |
Why?
|
| Middle Aged | 3 | 2022 | 220359 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 14661 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2009 | 1180 | 0.010 |
Why?
|
| United States | 3 | 2023 | 72448 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2014 | 3527 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 6498 | 0.010 |
Why?
|
| Aged | 3 | 2023 | 169143 | 0.010 |
Why?
|
| Benzophenanthridines | 1 | 2001 | 27 | 0.010 |
Why?
|
| Phenanthridines | 1 | 2001 | 51 | 0.010 |
Why?
|
| Liver Circulation | 1 | 2001 | 159 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2000 | 50 | 0.010 |
Why?
|
| Fluorouracil | 1 | 2006 | 1631 | 0.010 |
Why?
|
| Inflammation | 1 | 2000 | 10755 | 0.010 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2000 | 46 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2006 | 1791 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2000 | 108 | 0.010 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2000 | 58 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2001 | 412 | 0.010 |
Why?
|
| Alkaloids | 1 | 2001 | 194 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2000 | 212 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 3465 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 2000 | 243 | 0.010 |
Why?
|
| Female | 4 | 2023 | 391246 | 0.010 |
Why?
|
| Endothelium | 1 | 2001 | 764 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2000 | 585 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2001 | 780 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10826 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2006 | 3530 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2000 | 698 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2000 | 655 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2009 | 5508 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 7475 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15840 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2000 | 1187 | 0.010 |
Why?
|
| Protein Transport | 1 | 2000 | 1964 | 0.010 |
Why?
|
| Animals | 3 | 2001 | 167960 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2000 | 1313 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 8552 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2014 | 64981 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2014 | 24102 | 0.010 |
Why?
|
| Ischemia | 1 | 2001 | 1893 | 0.010 |
Why?
|
| Swine | 1 | 2001 | 5899 | 0.010 |
Why?
|
| Adult | 2 | 2006 | 220007 | 0.010 |
Why?
|
| Logistic Models | 1 | 2006 | 13312 | 0.010 |
Why?
|
| Graft Survival | 1 | 2001 | 3795 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2000 | 4000 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2009 | 80345 | 0.010 |
Why?
|
| Cell Movement | 1 | 2000 | 5206 | 0.000 |
Why?
|
| Proteins | 1 | 2000 | 6029 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2006 | 15679 | 0.000 |
Why?
|
Concepts
(128)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_